SANDEEP K. THAKKAR
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology
- Where
- IRVINE, CA
- NPI
- 1740454586
- Received
- $2,054,122 in 3,348 records, 2019 to 2025 ($1,998,492 general, $55,630 research)
- As principal investigator
- $161,067 of research payments to others in 29 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 495 | $370,237 |
| 2025 | Research payment | 4 | $5,635 |
| 2024 | General payment | 472 | $264,903 |
| 2024 | Research payment | 4 | $6,275 |
| 2023 | General payment | 431 | $233,212 |
| 2023 | Research payment | 6 | $7,650 |
| 2022 | General payment | 516 | $279,736 |
| 2022 | Research payment | 6 | $10,350 |
| 2021 | General payment | 442 | $296,044 |
| 2020 | General payment | 356 | $202,542 |
| 2020 | Research payment | 8 | $11,207 |
| 2019 | General payment | 601 | $351,814 |
| 2019 | Research payment | 7 | $14,512 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 521 | $1,309,275 |
| Consulting Fee | 119 | $285,100 |
| Travel and Lodging | 529 | $199,976 |
| Honoraria | 77 | $134,095 |
| Food and Beverage | 2,057 | $64,559 |
| Research payment | 35 | $55,630 |
| Education | 10 | $5,485 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-19 | ABBVIE INC. | $2,800 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-12-19 | Merz Pharmaceuticals, LLC | $1,320 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INBRIJA Drug, Parkinson's Disease | 2025 | |
| 2025-12-19 | Merz Pharmaceuticals, LLC | $1,320 | Travel and Lodging | Cash or cash equivalent | INBRIJA Drug, Parkinson's Disease | 2025 | |
| 2025-12-18 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-12-17 | Amneal Pharmaceuticals LLC | $27 | Food and Beverage | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-12-17 | Teva Pharmaceuticals USA, Inc. | $18 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-12-16 | ABBVIE INC. | $1,050 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-12-16 | Boston Scientific Corporation | $22 | Food and Beverage | In-kind items and services | General - DBS Device, General - DBS_NMD | 2025 | |
| 2025-12-12 | ACADIA Pharmaceuticals Inc | $19 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-12-11 | ABBVIE INC. | $2,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-12-10 | Merz Pharmaceuticals, LLC | $31 | Food and Beverage | In-kind items and services | INBRIJA Drug, Parkinson's Disease | 2025 | |
| 2025-12-10 | Amneal Pharmaceuticals LLC | $14 | Food and Beverage | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-12-09 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-12-04 | ABBVIE INC. | $4,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-12-04 | ABBVIE INC. | $2,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-12-04 | Merz Pharmaceuticals, LLC | $638 | Travel and Lodging | In-kind items and services | INBRIJA Drug, Parkinson's Disease | 2025 | |
| 2025-12-04 | Merz Pharmaceuticals, LLC | $125 | Food and Beverage | In-kind items and services | INBRIJA Drug, Parkinson's Disease | 2025 | |
| 2025-12-04 | Teva Pharmaceuticals USA, Inc. | $17 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-12-04 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-12-03 | ACADIA Pharmaceuticals Inc | $37 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-12-02 | Medtronic, Inc. | $6,860 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-12-02 | Neurocrine BioSciences, Inc. | $3,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-12-02 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-25 | Tonix Medicines, Inc. | $17 | Food and Beverage | In-kind items and services | ZEMBRACE SYMTOUCH Drug, NEUROLOGY | 2025 | |
| 2025-11-21 | ACADIA Pharmaceuticals Inc | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-11-21 | Axsome Therapeutics, Inc. | $28 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-11-20 | Teva Pharmaceuticals USA, Inc. | $5,415 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-20 | ABBVIE INC. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-11-20 | Teva Pharmaceuticals USA, Inc. | $1,013 | Travel and Lodging | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-20 | Teva Pharmaceuticals USA, Inc. | $128 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-20 | Amneal Pharmaceuticals LLC | $14 | Food and Beverage | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-11-19 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-11-19 | Teva Pharmaceuticals USA, Inc. | $9 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-17 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-11-17 | Neurocrine BioSciences, Inc. | $5 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-16 | Medtronic, Inc. | $318 | Travel and Lodging | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-11-14 | Medtronic, Inc. | $1,470 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-11-14 | Medtronic, Inc. | $125 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-11-13 | Medtronic, Inc. | $189 | Travel and Lodging | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-11-13 | Medtronic, Inc. | $126 | Travel and Lodging | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-11-13 | Medtronic, Inc. | $32 | Travel and Lodging | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-11-13 | Teva Pharmaceuticals USA, Inc. | $22 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-12 | MDD US Operations, LLC | $3,640 | Honoraria | Cash or cash equivalent | 2025 | ||
| 2025-11-12 | MDD US Operations, LLC | $718 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-11-12 | ABBVIE INC. | $298 | Travel and Lodging | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-11-12 | ABBVIE INC. | $104 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-11-12 | MDD US Operations, LLC | $26 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-11-11 | Merz Pharmaceuticals, LLC | $440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INBRIJA Drug, Parkinson's Disease | 2025 | |
| 2025-11-11 | Merz Pharmaceuticals, LLC | $21 | Food and Beverage | In-kind items and services | INBRIJA Drug, Parkinson's Disease | 2025 | |
| 2025-11-11 | MDD US Operations, LLC | $11 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-11-08 | ABBVIE INC. | $130 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-11-08 | ABBVIE INC. | $54 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-08 | ABBVIE INC. | $40 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-08 | ABBVIE INC. | $22 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-08 | ABBVIE INC. | $17 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-08 | ACADIA Pharmaceuticals Inc | $13 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-11-08 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-08 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-07 | ABBVIE INC. | $194 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-07 | ABBVIE INC. | $131 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-07 | ACADIA Pharmaceuticals Inc | $106 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-11-07 | ABBVIE INC. | $48 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-11-07 | Neurocrine BioSciences, Inc. | $23 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-07 | PFIZER INC. | $7 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-05 | Amneal Pharmaceuticals LLC | $25 | Food and Beverage | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-10-31 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-10-31 | Boston Scientific Corporation | $21 | Food and Beverage | In-kind items and services | General - DBS Device, General - DBS_NMD | 2025 | |
| 2025-10-30 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-10-30 | Ipsen Biopharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | Dysport Drug, Neurology | 2025 | |
| 2025-10-29 | Teva Pharmaceuticals USA, Inc. | $24 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-28 | ABBVIE INC. | $525 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-10-28 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-27 | Merz Pharmaceuticals, LLC | $138 | Food and Beverage | In-kind items and services | INBRIJA Drug, Parkinson's Disease | 2025 | |
| 2025-10-24 | ABBVIE INC. | $87 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-10-23 | ABBVIE INC. | $2,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-10-23 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-22 | Neurocrine BioSciences, Inc. | $984 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-22 | Neurocrine BioSciences, Inc. | $121 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-22 | Amneal Pharmaceuticals LLC | $28 | Food and Beverage | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-10-22 | Axsome Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-10-21 | Amneal Pharmaceuticals LLC | $3,961 | Honoraria | Cash or cash equivalent | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-10-17 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-17 | Neurocrine BioSciences, Inc. | $27 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-16 | Neurocrine BioSciences, Inc. | $3 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-15 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-10-09 | Medtronic, Inc. | $2,450 | Consulting Fee | Cash or cash equivalent | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-10-08 | Amneal Pharmaceuticals LLC | $125 | Food and Beverage | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-10-07 | Amneal Pharmaceuticals LLC | $313 | Travel and Lodging | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-10-07 | Medtronic, Inc. | $89 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-10-07 | Neurocrine BioSciences, Inc. | $40 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-06 | ABBVIE INC. | $130 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-10-05 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-10-04 | Medtronic, Inc. | $129 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-10-04 | ACADIA Pharmaceuticals Inc | $104 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-10-03 | Merz Pharmaceuticals, LLC | $145 | Food and Beverage | In-kind items and services | INBRIJA Drug, Parkinson's Disease | 2025 | |
| 2025-10-02 | Teva Pharmaceuticals USA, Inc. | $23 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-01 | Medtronic, Inc. | $980 | Research payment | Cash or cash equivalent | ACTIVA PC Device, Deep Brain Neurostimulation | PSR-DBS | 2025 |
| 2025-10-01 | MDD US Operations, LLC | $20 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-10-01 | Medtronic, Inc. | $9 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-10-01 | MDD US Operations, LLC | $3 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-09-30 | Neurocrine BioSciences, Inc. | $3,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-30 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-30 | MDD US Operations, LLC | $6 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-09-29 | Neurocrine BioSciences, Inc. | $80 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-26 | Medtronic, Inc. | $1,784 | Travel and Lodging | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-09-26 | Teva Pharmaceuticals USA, Inc. | $111 | Education | In-kind items and services | 2025 | ||
| 2025-09-26 | Medtronic, Inc. | $35 | Travel and Lodging | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-09-26 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-09-25 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-25 | Teva Pharmaceuticals USA, Inc. | $18 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-24 | Neurocrine BioSciences, Inc. | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-24 | Amneal Pharmaceuticals LLC | $27 | Food and Beverage | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-09-23 | Neurocrine BioSciences, Inc. | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-23 | ACADIA Pharmaceuticals Inc | $39 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-09-20 | MDD US Operations, LLC | $5 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-09-19 | ACADIA Pharmaceuticals Inc | $23 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-09-17 | MDD US Operations, LLC | $1,260 | Honoraria | Cash or cash equivalent | 2025 | ||
| 2025-09-17 | PFIZER INC. | $25 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-16 | Amneal Pharmaceuticals LLC | $234 | Travel and Lodging | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-09-15 | Medtronic, Inc. | $8 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-09-12 | ACADIA Pharmaceuticals Inc | $33 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-09-11 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-09-11 | Ipsen Biopharmaceuticals, Inc | $15 | Food and Beverage | In-kind items and services | Dysport Drug, Neurology | 2025 | |
| 2025-09-11 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-09-10 | Amneal Pharmaceuticals LLC | $2,330 | Honoraria | Cash or cash equivalent | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-09-09 | MDD US Operations, LLC | $3 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-09-08 | ABBVIE INC. | $122 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-09-04 | Amneal Pharmaceuticals LLC | $124 | Food and Beverage | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-09-04 | Amneal Pharmaceuticals LLC | $27 | Food and Beverage | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-09-04 | ACADIA Pharmaceuticals Inc | $25 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-09-04 | Neurocrine BioSciences, Inc. | $15 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-04 | Neurocrine BioSciences, Inc. | $9 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-29 | PFIZER INC. | $23 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-08-29 | Ipsen Biopharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | Dysport Drug, Neurology | 2025 | |
| 2025-08-29 | Medtronic, Inc. | $11 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-08-27 | Neurocrine BioSciences, Inc. | $5,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-27 | Medtronic, Inc. | $1,470 | Research payment | Cash or cash equivalent | ACTIVA PC Device, Deep Brain Neurostimulation | PSR-DBS | 2025 |
| 2025-08-27 | Neurocrine BioSciences, Inc. | $433 | Travel and Lodging | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-27 | Amneal Pharmaceuticals LLC | $28 | Food and Beverage | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-08-27 | Neurocrine BioSciences, Inc. | $21 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-27 | Teva Pharmaceuticals USA, Inc. | $9 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-26 | Neurocrine BioSciences, Inc. | $5 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-25 | Teva Pharmaceuticals USA, Inc. | $750 | Consulting Fee | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-22 | ACADIA Pharmaceuticals Inc | $13 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-08-22 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-08-21 | MDD US Operations, LLC | $24 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-08-20 | Amneal Pharmaceuticals LLC | $12 | Food and Beverage | In-kind items and services | CREXONT Drug, NEUROLOGY | 2025 | |
| 2025-08-16 | ABBVIE INC. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-16 | ABBVIE INC. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-16 | ABBVIE INC. | $231 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-16 | ABBVIE INC. | $90 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-16 | ABBVIE INC. | $81 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-16 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-16 | ABBVIE INC. | $0 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-15 | ABBVIE INC. | $4,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-15 | ABBVIE INC. | $3,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-15 | ABBVIE INC. | $1,099 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-15 | ABBVIE INC. | $430 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-15 | ABBVIE INC. | $281 | Travel and Lodging | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-15 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-15 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | BOTOX Biological, NEUROSCIENCE | 2025 | |
| 2025-08-14 | ABBVIE INC. | $3,575 | Consulting Fee | Cash or cash equivalent | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-08-14 | ACADIA Pharmaceuticals Inc | $20 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-08-14 | Teva Pharmaceuticals USA, Inc. | $16 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-14 | MDD US Operations, LLC | $7 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-08-13 | Neurocrine BioSciences, Inc. | $3,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-13 | Axsome Therapeutics, Inc. | $28 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-08-12 | ABBVIE INC. | $2,275 | Consulting Fee | Cash or cash equivalent | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-08-12 | ABBVIE INC. | $243 | Consulting Fee | Cash or cash equivalent | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-08-11 | Medtronic, Inc. | $9 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-08-09 | ABBVIE INC. | $4,025 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-08-09 | ABBVIE INC. | $582 | Travel and Lodging | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-08-09 | ABBVIE INC. | $192 | Travel and Lodging | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-08-09 | ABBVIE INC. | $67 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-08-09 | ABBVIE INC. | $57 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-08-09 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-08-09 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-08-08 | MDD US Operations, LLC | $880 | Honoraria | Cash or cash equivalent | 2025 | ||
| 2025-08-08 | PFIZER INC. | $8 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-08-08 | PFIZER INC. | $0 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-08-07 | ACADIA Pharmaceuticals Inc | $124 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-08-07 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-06 | Teva Pharmaceuticals USA, Inc. | $5,415 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-06 | Teva Pharmaceuticals USA, Inc. | $900 | Travel and Lodging | Cash or cash equivalent | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-06 | Teva Pharmaceuticals USA, Inc. | $87 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-06 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-08-06 | Ipsen Biopharmaceuticals, Inc | $17 | Food and Beverage | In-kind items and services | Dysport Drug, Neurology | 2025 | |
| 2025-07-31 | MDD US Operations, LLC | $4 | Food and Beverage | In-kind items and services | Qelbree Drug, VILOXAZINE HYDROCHLORIDE | 2025 | |
| 2025-07-30 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-07-29 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-28 | Medtronic, Inc. | $7 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-07-25 | ACADIA Pharmaceuticals Inc | $1,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-07-25 | ACADIA Pharmaceuticals Inc | $17 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-07-25 | ACADIA Pharmaceuticals Inc | $2 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-07-24 | Medtronic, Inc. | $6,860 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-07-23 | Teva Pharmaceuticals USA, Inc. | $18 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-07-22 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-07-18 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-17 | Medtronic, Inc. | $318 | Travel and Lodging | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 | |
| 2025-07-17 | Medtronic, Inc. | $108 | Food and Beverage | In-kind items and services | PERCEPT PC BRAINSENSE Device, Deep Brain Neurostimulation | 2025 |
The latest 200 records of 3,348.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2022-08-25 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $1,500 | AN OPEN-LABEL EXTENSION STUDY OF THE SAFETY AND CLINICAL UTILITY OF IPX203 IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FL | 2022 |
| 2022-05-12 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $12,229 | A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in | 2022 |
| 2022-04-27 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $5,597 | AN OPEN-LABEL EXTENSION STUDY OF THE SAFETY AND CLINICAL UTILITY OF IPX203 IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FL | 2022 |
| 2022-03-24 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $1,722 | AN OPEN-LABEL EXTENSION STUDY OF THE SAFETY AND CLINICAL UTILITY OF IPX203 IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FL | 2022 |
| 2021-12-16 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $1,500 | A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in | 2021 |
| 2021-10-28 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $9,257 | An Open-label Extension Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease Patients With Motor Fl | 2021 |
| 2021-07-29 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $4,362 | An Open-label Extension Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease Patients With Motor Fl | 2021 |
| 2021-07-15 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $1,462 | A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in | 2021 |
| 2021-05-27 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $4,362 | An Open-label Extension Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease Patients With Motor Fl | 2021 |
| 2021-04-28 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $5,222 | A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in | 2021 |
| 2021-04-22 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $1,937 | An Open-label Extension Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease Patients With Motor Fl | 2021 |
| 2021-04-08 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $2,719 | A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in | 2021 |
| 2021-03-11 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $2,936 | A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in | 2021 |
| 2021-02-18 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $1,702 | A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in | 2021 |
| 2021-02-18 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $4,573 | A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in | 2021 |
| 2021-02-11 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $1,722 | An Open-label Extension Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease Patients With Motor Fl | 2021 |
| 2021-02-04 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $4,477 | An Open-label Extension Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease Patients With Motor Fl | 2021 |
| 2021-01-21 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $1,980 | A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in | 2021 |
| 2021-01-14 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $1,722 | An Open-label Extension Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease Patients With Motor Fl | 2021 |
| 2021-01-14 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $2,310 | A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in | 2021 |
| 2020-12-17 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $1,980 | A RANDOMIZED CONTROLLED STUDY TO COMPARE THE SAFETY AND EFFICACY OF IPX203 WITH IMMEDIATE-RELEASE CARBIDOPA-LEVODOPA IN | 2020 |
| 2020-12-17 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $19,692 | A RANDOMIZED CONTROLLED STUDY TO COMPARE THE SAFETY AND EFFICACY OF IPX203 WITH IMMEDIATE-RELEASE CARBIDOPA-LEVODOPA IN | 2020 |
| 2020-10-15 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $1,722 | AN OPEN-LABEL EXTENSION STUDY OF THE SAFETY AND CLINICAL UTILITY OF IPX203 IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FL | 2020 |
| 2020-10-15 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $350 | A RANDOMIZED CONTROLLED STUDY TO COMPARE THE SAFETY AND EFFICACY OF IPX203 WITH IMMEDIATE-RELEASE CARBIDOPA-LEVODOPA IN | 2020 |
| 2020-10-15 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $18,100 | A RANDOMIZED CONTROLLED STUDY TO COMPARE THE SAFETY AND EFFICACY OF IPX203 WITH IMMEDIATE-RELEASE CARBIDOPA-LEVODOPA IN | 2020 |
| 2020-09-03 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $7,918 | AN OPEN-LABEL EXTENSION STUDY OF THE SAFETY AND CLINICAL UTILITY OF IPX203 IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FL | 2020 |
| 2020-07-23 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $19,547 | A RANDOMIZED CONTROLLED STUDY TO COMPARE THE SAFETY AND EFFICACY OF IPX203 WITH IMMEDIATE-RELEASE CARBIDOPA-LEVODOPA IN | 2020 |
| 2020-05-07 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $11,457 | A RANDOMIZED CONTROLLED STUDY TO COMPARE THE SAFETY AND EFFICACY OF IPX203 WITH IMMEDIATE-RELEASE CARBIDOPA-LEVODOPA IN | 2020 |
| 2019-11-08 | Amneal Pharmaceuticals LLC | HOAG MEMORIAL HOSPITAL PRESBYTERIAN | $7,000 | A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Irvine, CA, county Orange County, CA, state California; placed by its city name.
| Measure | Place (city or town) Irvine, CA | County Orange County, CA | State California |
|---|---|---|---|
| Population B01003 | 311,690 | 3,165,820 | 39,287,377 |
| Population, 2020 census P1 | 307,670 | 3,186,989 | 39,538,223 |
| Median age B01002 | 34.0 | 39.4 | 37.9 |
| Under 18 B01001 | 21.7% | 21.0% | 22.0% |
| 65 and over B01001 | 10.8% | 16.3% | 15.7% |
| Households B11001 | 112,091 | 1,082,960 | 13,548,091 |
| Foreign born B05002 | 39.8% | 30.4% | 27.0% |
| Median household income B19013 | $136,719 | $116,289 | $99,122 |
| Median family income B19113 | $167,999 | $132,827 | $113,346 |
| Per capita income B19301 | $64,055 | $54,557 | $49,513 |
| Poverty rate B17001 | 10.8% | 9.5% | 12.0% |
| Unemployment rate B23025 | 5.9% | 5.4% | 6.6% |
| Civilian labor force B23025 | 168,889 | 1,692,091 | 20,068,466 |
| Mean commute (minutes) B08013 | 24.7 | 26.7 | 28.7 |
| Bachelor's degree or higher B15003 | 70.6% | 44.1% | 37.1% |
| Housing units B25001 | 120,206 | 1,146,169 | 14,644,735 |
| Owner-occupied B25003 | 44.5% | 56.4% | 55.9% |
| Renters B25003 | 55.5% | 43.6% | 44.1% |
| Median home value B25077 | $1,191,500 | $962,600 | $734,700 |
| Median gross rent B25064 | $2,997 | $2,434 | $2,036 |
| White, not Hispanic B03002 | 34.3% | 36.9% | 33.8% |
| Black B03002 | 1.9% | 1.5% | 5.2% |
| Hispanic or Latino B03002 | 11.4% | 34.2% | 40.2% |
| Asian B03002 | 44.6% | 22.2% | 15.3% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Irvine, CA.
Comments